Table 2.
Laboratory test results of the 74 COVID-19 patients.
| Median (IQR) | |||||
| Items | Total (n = 74) | ICU patient (n = 18) | Non-ICU patient (n = 56) | Normal range | P |
| White blood cell count, × 109/L | 5.9 (4.7–6.6) | 5.6 (4.2–6.6) | 5.1 (4.1–5.6) | 3.5–9.5 | .929 |
| Neutrophil count, ×109/L | 3.8 (2.5–4.8) | 4.1 (3.4–5.7) | 3.7 (2.7–4.3) | 1.8–6.3 | .77 |
| Lymphocyte count, × 109/L | 1.1 (0.6–1.5) | 0.8 (0.5–1.1) | 1.1 (0.7–1.8) | 1.1–3.2 | .022 |
| <1.1 × 109/L, (%) | 34 (45.95) | 11 (61.11) | 23 (41.07) | .138 | |
| Monocyte count, × 109/L | 0.4 (0.3–0.5) | 0.3 (0.2–0.4) | 0.3 (0.4–0.5) | 0.1–0.6 | .127 |
| Platelet count, × 109/L | 166 (131–221) | 136 (107–168) | 200 (136–233) | 125.0–350.0 | <.001 |
| ESR, mm/h | 20 (10–33) | 31 (17–79) | 18 (8–31) | 0–20.0 | .011 |
| CRP, mg/L | 17.5 (4.5–36.2) | 43.3 (10.9–79.2) | 13.4 (4.0–26.9) | 0–8.0 | .015 |
| CD4/CD8 | 1.8 (1.6–2.2) | 1.9 (1.7–2.2) | 1.8 (1.6–2.2) | 1.1–1.7 | .532 |
| <1.1, (%) | 19 (25.68) | 9 (50.00) | 10 (17.86) | .007 | |
| Procalcitonin, ng/mL | 0.2 (0.1–0.4) | 0.3 (0.2–0.7) | 0.2 (0.1–0.4) | 0–0.5 | .056 |
| IL-6, pg/mL | 6.5 (5.6–7.3) | 7.1 (6.0–8.4) | 6.3 (5.0–7.0) | <7 | .742 |
| Creatine kinase, U/L | 90 (57–132) | 127 (58–266) | 89 (56–117) | 22–269 | .134 |
| Creatine kinase isoenzyme, U/L | 12 (10–17) | 11 (9–16) | 12 (10–18) | 0–225 | .321 |
| Lactate dehydrogenase, U/L | 228 (177–290) | 300 (242–292) | 201 (166–268) | 125–250 | <.001 |
| High-sensitivity troponin, pg/mL | 0.08 (0.06–0.12) | 0.10 (0.07–0.36) | 0.08 (0.06–0.11) | 0–0.3 | .181 |
| Alanine aminotransferase, U/L | 29 (17–44) | 29 (23–41) | 29 (16–45) | 9–50 | .483 |
| Aspartate aminotransferase, U/L | 31 (23–49) | 35 (28–42) | 29 (21–39) | 15–45 | .294 |
| Albumin, g/l | 43 (37–48) | 38 (34–44) | 45 (39–49) | 40–55 | .072 |
| Total bilirubin, mmol/L | 16.5 (11.2–23.5) | 13.9 (9.7–18.4) | 17.1 (12.9–23.8) | 3.4–21 | .377 |
| Creatinine, μmol/L | 68 (60–80) | 71 (61–81) | 68 (60–80) | 57–111 | .658 |
| Urea nitrogen, mmol/L | 4.3 (3.4–5.5) | 4.9 (2.9–6.5) | 4.2 (3.4–5.5) | 3.1–8.0 | .764 |
| Prothrombin time, s | 14.2 (13.6–15.1) | 14.2 (14.8–15.4) | 14 (13.1–14.6) | 9.5–14.5 | .072 |
| Activated partial thromboplastin time, s | 39.3 (34.4–42.3) | 37.2 (30.2–38.9) | 40.0 (35.8–42.3) | 20.0–40.0 | .028 |
| D-dimer, mg/L | 0.3 (0.1–0.5) | 0.5 (0.2–0.6) | 0.2 (0.1–0.4) | 0–1.1 | .152 |